These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10975688)

  • 1. Psychostimulants in supportive care.
    Homsi J; Walsh D; Nelson KA
    Support Care Cancer; 2000 Sep; 8(5):385-97. PubMed ID: 10975688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical use of psychostimulants: an overview.
    Holmes VF
    Int J Psychiatry Med; 1995; 25(1):1-19. PubMed ID: 7649714
    [No Abstract]   [Full Text] [Related]  

  • 3. Gilles de la Tourette's syndrome: effects of stimulant drugs.
    Erenberg G; Cruse RP; Rothner AD
    Neurology; 1985 Sep; 35(9):1346-8. PubMed ID: 2862607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychostimulants in psychiatry.
    Warneke L
    Can J Psychiatry; 1990 Feb; 35(1):3-10. PubMed ID: 2180548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoidance acquisition and CNS stimulants.
    Kulkarni AS
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(4):394-400. PubMed ID: 4403235
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
    Kociancic T; Reed MD; Findling RL
    Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of narcolepsy in pregnancy.
    Hoover-Stevens S; Kovacevic-Ristanovic R
    Clin Neuropharmacol; 2000; 23(4):175-81. PubMed ID: 11020119
    [No Abstract]   [Full Text] [Related]  

  • 10. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
    Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
    Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of psychostimulants in general psychiatry. A reconsideration.
    Chiarello RJ; Cole JO
    Arch Gen Psychiatry; 1987 Mar; 44(3):286-95. PubMed ID: 2881528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
    Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
    Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions with psychostimulants.
    Markowitz JS; Morrison SD; DeVane CL
    Int Clin Psychopharmacol; 1999 Jan; 14(1):1-18. PubMed ID: 10221637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nursing alert. Understanding the spectrum of cerebral stimulants (continuing education).
    Burgess KE
    Nursing; 1985 Jul; 15(7):50-6. PubMed ID: 2989741
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stimulant therapy in children].
    Steinhausen HC
    Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.